An attempt to patent a medicine already patented in the U.S. and elsewhere, and currently being developed by U.S. drugmaker Gilead Sciences, raises serious intellectual

An attempt to patent a medicine already patented in the U.S. and elsewhere, and currently being developed by U.S. drugmaker Gilead Sciences, raises serious intellectual
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over